| Literature DB >> 29463544 |
Melanie T Cushion1,2, Aleksey Porollo3,4,5, Alan Ashbaugh6, Keeley Hendrix6, Michael J Linke2, Nikeya Tisdale6, Steven G Sayson6.
Abstract
The echinocandins are a class of antifungal agents that target β-1,3-d-glucan (BG) biosynthesis. In the ascigerous Pneumocystis species, treatment with these drugs depletes the ascus life cycle stage, which contains BG, but large numbers of forms which do not express BG remain in the infected lungs. In the present study, the gene expression profiles of Pneumocystis murina were compared between infected, untreated mice and mice treated with anidulafungin for 2 weeks to understand the metabolism of the persisting forms. Almost 80 genes were significantly up- or downregulated. Like other fungi exposed to echinocandins, genes associated with sexual replication, cell wall integrity, cell cycle arrest, and stress comprised the strongest upregulated signals in P. murina from the treated mice. The upregulation of the P. murina β-1,3-d-glucan endohydrolase and endo-1,3-glucanase was notable and may explain the disappearance of the existing asci in the lungs of treated mice since both enzymes can degrade BG. The biochemical measurement of BG in the lungs of treated mice and fluorescence microscopy with an anti-BG antibody supported the loss of BG. Downregulated signals included genes involved in cell replication, genome stability, and ribosomal biogenesis and function and the Pneumocystis-specific genes encoding the major surface glycoproteins (Msg). These studies suggest that P. murina attempted to undergo sexual replication in response to a stressed environment and was halted in any type of proliferative cycle, likely due to a lack of BG. Asci appear to be a required part of the life cycle stage of Pneumocystis, and BG may be needed to facilitate progression through the life cycle via sexual replication.Entities:
Keywords: AIDS related; Pneumocystis; Pneumocystis pneumonia; anidulafungin; antifungal agents; ascus; echinocandin; opportunistic fungi; sexual development
Mesh:
Substances:
Year: 2018 PMID: 29463544 PMCID: PMC5923105 DOI: 10.1128/AAC.02513-17
Source DB: PubMed Journal: Antimicrob Agents Chemother ISSN: 0066-4804 Impact factor: 5.191
FIG 1“Trophic” and ascus burdens pre-and postcessation of anidulafungin treatment. Two groups of mice were evaluated in this study. One group of P. murina-infected mice was treated with anidulafungin for 2 weeks, after which treatment ceased. The other group of mice was not treated. At the 2-week time point, 6 mice from the untreated group were sacrificed (“Untx”) and 6 mice that had been treated with anidulafungin were sacrificed (“Tx Day 0”). Mice were then sampled for organism burdens 2, 4, 6, and 8 days after ceasing the anidulafungin treatment (“Tx Day 2, 4, 6, or 8”). “Trophic” burdens are shown in panel A, and asci are shown in panel B. Blue bars indicate significant differences compared to the untreated mice at day 0; red bars indicate significant differences compared to the anidulafungin-treated mice at day 0. Significance was calculated using Newman-Keuls multiple-comparison test after calculation of ANOVA. Significance was accepted at P < 0.05. The green line in panel B denotes the level of detection by microscopic enumeration. No asci were observed in slides from these mouse lungs as log10 4.2 is the level of microscopic detection. (At this time, we are unsure whether the forms left behind after anidulafungin treatment are all trophic forms, whether they include asci without cell walls or include transitional stages. Nonetheless, they do not express BG. Thus, the nuclei of all lingering forms were enumerated.)
FIG 2Fluorescent detection of β-1,3-d-glucan and Msg in P. murina cells from nontreated and anidulafungin-treated mice. Panels A through H are representative asci from untreated mice. Panels I through P are representative organisms from treated mice. Panels A and E show the morphology of P. murina cells observed under phase contrast in untreated, infected mice, while anidulafungin-treated P. murina cells displayed an atypical, nonspherical morphology (I and M). The 4 panels in each of the 4 representative groups are marked and include phase-contrast micrographs, reaction with an anti-Msg antibody, reaction with an anti-BG monoclonal antibody, and the merged panels. Detection of Msg family proteins was observed in both untreated (B and F) and anidulafungin-treated (J and N) P. murina cells. β-1,3-d-Glucan was detected in untreated P. murina cells (C and G) and shows coexpression with Msg family proteins (D and H). β-1,3-d-Glucan is notably absent or minimal in anidulafungin-treated P. murina cells (K and O). Note the aberrant morphologies of the treated organisms. Scale bars = 2 μm.
P. murina genes significantly upregulated in the anidulafungin-treated mice
| Function and GenBank ID | Gene product description | Expression (TPM) | FC (Tx0d/Untx) | E value | Identity, organism, or HP | |
|---|---|---|---|---|---|---|
| UnTx | Tx0d | |||||
| Meiosis and cell wall integrity | ||||||
| | Gas4/5p | 9.266 | 100.427 | 10.838 | 1e−128/8e−121 | 49%/50%, Sp |
| | Mitogen-activated kinase kinase MKK2 (Pek1) | 8.969 | 24.607 | 2.743 | 4e−113 | 52%, Sp |
| | Glucan-1,3-β-glucosidase; glycosyl hydrolase family 17 | 76.321 | 203.799 | 2.67 | 8e−67 | 38%, Sc |
| | Flavin carrier partial (FLC2) | 46.014 | 117.458 | 2.553 | 3e−134 | 37%, Sc |
| | GPI-anchored cell surface protein (Meu10) | 281.502 | 653.933 | 2.323 | 9e−50 | 33%, Sp |
| | Lsp1 (sphingolipid long-chain base-responsive) | 56.259 | 127.557 | 2.267 | 3e−129 | 64%, Sc |
| | Meu14 (eisosome component PIL1 domain) | 100.218 | 201.691 | 2.013 | 4e−63 | 43%, Sp |
| | Meu5/Crp79 | 81.402 | 155.74 | 1.913 | 2e−31 | 59%, Sp |
| | Meiotic recombination (Dmc1) | 324.034 | 599.66 | 1.851 | 0.0 | 73%, Sp |
| | Bni4 | 76.109 | 135.674 | 1.783 | 2e−13 | 55%, Sc |
| | Endo-1,3-β-glucanase (Eng1) | 814.065 | 1,404.655 | 1.725 | 1e−09 | 47%, Sp |
| | Ras guanine-nucleotide exchange (CDC25) | 95.075 | 154.987 | 1.63 | 3e−50 | 32%, Sc |
| | Meiosis specific coiled-coil (Mcp7) | 144.307 | 233.293 | 1.617 | 1e−40 | 59%, Sp |
| | Ubiquitin ligase complex F-box (GRR1) | 41.962 | 65.299 | 1.556 | 9e−108 | 40%, Sc |
| Stress response | ||||||
| | Hsp16 | 526.759 | 1,574.851 | 2.99 | 1e−12 | 33%, Sp |
| | Hsp72 (Ssa1/2) | 2,743.877 | 5,897.959 | 2.149 | 0.0 | 80%, Sp |
| | 16.314 | 34.202 | 2.097 | 0.0 | 90%, Pc | |
| | Hsp90 | 5,412.202 | 11,260.631 | 2.081 | 0.0 | 74%, Sp |
| | CDP-diacylglycerol-glycerol-3-phosphate 3-phosphatidyltransferase | 172.565 | 294.883 | 1.709 | 5e−39 | 44%, Sp |
| | ARM repeat-containing; Pumilio superfamily | 126.501 | 265.395 | 2.098 | 6e−114 | 55%, Sp |
| | Mcp2; Pumilio family RNA binding repeat | 81.233 | 153.703 | 1.892 | 2e−156 | 59%, Sp |
| | rRNA processing Ipi1 | 103.609 | 249.864 | 2.412 | 5e−17 | 30%, Sp |
| Unknown function | ||||||
| | Hypothetical protein PNEG_02270 | 213.783 | 1,089.16 | 5.095 | 1e−38 | 60%, HP T552_02826 (Pc) |
| | Hypothetical protein PNEG_03592 | 13.26 | 62.25 | 4.695 | 4e−135 | 58%, HP T552_02796 (Pc) |
| | Hypothetical protein PNEG_02419 | 7.402 | 34.202 | 4.62 | 9e−126 | 56%, HP T552_02796 (Pc) |
| | Hypothetical protein PNEG_02319 | 1,507.56 | 6,663.202 | 4.42 | 3e−92 | 60%, HP T552_02875 (Pc) |
| | Hypothetical protein PNEG_01236 | 25.974 | 89.449 | 3.444 | 1e−115 | 92%, HP T552_04055 (Pc) |
| | Hypothetical protein PNEG_02710 | 36.303 | 98.36 | 2.709 | 4e−132 | 67%, HP T552_01745 (Pc) |
| | Hypothetical protein PNEG_01837 | 504.601 | 1,088.405 | 2.157 | 1e−56 | 81%, HP T552_03116 (Pc) |
| | Hypothetical protein PNEG_03389 | 96.136 | 180.268 | 1.875 | 0.0 | 76%, HP T552_03364 (Pc) |
| | Hypothetical protein PNEG_00433 | 298.172 | 556.408 | 1.866 | 3e−77 | 91%, HP T552_00422 (Pc) |
| | Hypothetical protein PNEG_02491 | 189.756 | 316.926 | 1.67 | 9e−127 | 84%, HP T552_02724 (Pc) |
UnTx, P. murina extracted from infected, untreated mice. Expression is shown in transcripts per million (TPM).
Tx0d, P. murina extracted from infected mice treated with anidulafungin for 2 weeks. Expression is shown in TPM.
FC, fold change in P. murina gene expression between infected, untreated mice and mice treated with anidulafungin for 2 weeks.
E value of sequence homology to the known genes as reported by the NCBI SmartBLAST tool.
Sequence identity (percentage) to the known genes and organisms. Organism abbreviations: Sp, Schizosaccharomyces pombe; Sc, Saccharomyces cerevisiae; Pc, Pneumocystis carinii. HP, hypothetical protein for which the organism (in parentheses) and identity are for the closest species not P. murina in origin.
FIG 3Measurement of β-1,3-d-glucan in the lungs of untreated versus anidulafungin-treated mice. β-1,3-d-Glucan contents in the lungs of untreated (UnTx) and anidulafungin-treated (Anid Tx [1 mg/kg anidulafungin for 2 weeks]) mice were quantified with the Glucatell kit. Significantly more of the intact polymer was present in the untreated (UnTx) versus treated (Anid Tx) mouse lungs (1,511.2 ± 166 versus 398.9 ± 187 pg/ml; P = 0.0001).
Genes significantly downregulated in the anidulafungin-treated mice
| Function and GenBank ID | Gene product description | Expression (TPM) | FC (Untx/Tx0d) | E value | Identity, organism, or HP | |
|---|---|---|---|---|---|---|
| UnTx | Tx0d | |||||
| Meiosis and cell replication | ||||||
| | COP9 signalosome subunit 6 (Rpn8) | 8.374 | 1.799 | 4.656 | 4e−08 | 30%, Sc |
| | Adg3 | 6,110.184 | 1,861.178 | 3.283 | 2e−24 | 31%, Sp |
| | Pheromone P-factor receptor (Mam2) | 189.23 | 63.294 | 2.99 | 3e−42 | 33%, Sp |
| | Pheromone-regulated multi-spanning membrane (Prm1) | 299 | 130.057 | 2.299 | 6e−71 | 30%, Sp |
| | Zds1 | 41.528 | 19.808 | 2.097 | 2e−05 | 51%, Sp |
| | Calcium/calmodulin-dependent kinase (Srk1) | 180.769 | 101.829 | 1.775 | 2e−148 | 54%, Sp |
| | Single-stranded DNA binding protein (Ssb2) | 58.526 | 35.555 | 1.646 | 3e−35 | 37%, Sp |
| Mitochondrial function | ||||||
| | Mitochondrial endodeoxyribonuclease (Pnu1) | 1,136.987 | 398.104 | 2.856 | 6e−90 | 47%, Sp |
| | Mitochondrial import subunit (Tom22) | 178.033 | 94.027 | 1.893 | 1e−26 | 40%, Sp |
| | Cytochrome | 115.2 | 66.119 | 1.742 | 2e−18 | 41%, Sp |
| | Mitochondrial fission process 1 | 214.822 | 128.712 | 1.669 | 2e−14 | 32%, Hs |
| | Succinyl-ligase subunit α | 99.526 | 59.797 | 1.664 | 6e−147 | 71%, Sp |
| Genomic stability | ||||||
| | Elongation of fatty acids 3 (Elo3, Gns1/Sur4) | 108.911 | 50.703 | 2.148 | 4e−106 | 51%, Sp |
| | Cytoplasmic tRNA 2-thiolation 1 (Ctu1) | 591.814 | 320.682 | 1.845 | 3e−122 | 66%, Sp |
| Cell surface glycoproteins | ||||||
| | Major surface glycoprotein, partial | 3,717.198 | 1,834.282 | 2.027 | 1e−19 | 27%, Pj |
| | β-1,4-Mannosyltransferase (Alg1) | 123.64 | 62.336 | 1.983 | 5e−111 | 42%, Sp |
| | Major surface glycoprotein type II (Msr) | 9,403.617 | 4,921.901 | 1.911 | 9e−05 | 20%, Pc |
| | Major surface glycoprotein, partial | 1,820.35 | 979.567 | 1.858 | 1e−05 | 20%, Pj |
| | Major surface glycoprotein, partial | 1,425.251 | 784.158 | 1.818 | 4.5 | 20%, Pc |
| | Pig-F (predicted) | 116.727 | 70.473 | 1.656 | 7e−60 | 38%, Sp |
| Ribosomal biogenesis/function | ||||||
| | 40S ribosomal S6-A | 774.972 | 394.259 | 1.966 | 2e−149 | 100%, Pm |
| | rRNA-exonuclease (Rrp17) | 258.855 | 137.663 | 1.88 | 4e−08 | 46%, Sp |
| | rRNA processing (Fcf1) | 86.943 | 46.463 | 1.871 | 3e−77 | 61%, Sp |
| | 40S ribosomal S5 (S7) | 1,048.419 | 574.435 | 1.825 | 4e−76 | 59%, Sp |
| | Transcription elongation factor, Elf1 family | 60.632 | 36.027 | 1.683 | 2e−28 | 62%, Sp |
| | RNA-binding Tma20 (translational machinery-associated proteins) | 338.497 | 204.081 | 1.659 | 9e−70 | 54%, Sp |
| | 40S ribosomal S3 | 491.484 | 321.795 | 1.527 | 1e−132 | 86%, Sp |
| | 60S ribosomal protein L32 | 512.000 | 315.392 | 1.623 | 4e−54 | 66%, Sp |
| Cellular homeostasis/cell wall integrity | ||||||
| | Sho1 | 886.514 | 440.195 | 2.014 | 7e−16 | 31%, Sc |
| | Hal9 | 3,444.312 | 1,812.795 | 1.900 | 1e−04 | 41%, Sc |
| | Proteasome maturation factor (UMP1) | 375.847 | 201.411 | 1.866 | 2e−15 | 33%, Sc |
| | Prefoldin, β subunit (Yke2) | 940.315 | 520.950 | 1.805 | 6e−19 | 52%, Sc |
| Unknown function | ||||||
| | Hypothetical protein PNEG_01120 | 22.502 | 1.000 | 22.502 | NM | |
| | Hypothetical protein PNEG_00727 | 43.895 | 4.857 | 9.038 | NM | |
| | Hypothetical protein PNEG_00143 | 15.105 | 1.952 | 7.738 | 7e−24 | 89%, HP T552_01243 (Pc) |
| | Hypothetical protein PNEG_02411 | 2,864.366 | 518.069 | 5.529 | 4e−118 | 63%, HP T552_02964 (Pc) |
| | Hypothetical protein PNEG_04307 | 114.167 | 27.417 | 4.164 | 3e−28 | 69%, HP T552_01884 (Pc) |
| | Hypothetical protein PNEG_02866 | 75,752.191 | 37,354.644 | 2.028 | 3e−30 | 71%, HP T552_01591 (Pc) |
| | Armadillo-like helical | 195.497 | 99.319 | 1.968 | 0.0 | 88%, HP T552_03192 (Pc) |
| | Hypothetical protein PNEG_03437 | 1,425.251 | 784.158 | 1.818 | 9e−18 | 27%, HP T552_03404 (Pc) |
| | Hypothetical protein PNEG_02875 | 274.945 | 151.587 | 1.814 | 1e−98 | 89%, HP T552_02354 (Pc) |
| | P-loop containing nucleoside triphosphate hydrolase (function unassigned) | 109.213 | 65.845 | 1.659 | 1e−91 | 56%, Pl |
| | Haloacid dehalogenase-like hydrolase (HAD)-like | 56.259 | 35.679 | 1.577 | 1e−65 | 46%, Sp |
| | Hypothetical protein (mitochondrion) | 11,593.271 | 7,563.824 | 1.572 | 4e–60 | 50%, YP_009186399.1 |
UnTx, P. murina extracted from infected, untreated mice. Expression is shown in transcripts per million (TPM).
Tx0d, P. murina extracted from infected mice treated with anidulafungin for 2 weeks. Expression is shown in TPM.
FC, fold change in P. murina gene expression between infected, untreated mice and mice treated with anidulafungin for 2 weeks.
E value of sequence homology to the known genes as reported by the NCBI SmartBLAST tool. NM, no matches with known proteins.
Sequence identity (percentage) to the known genes and organisms. Organism abbreviations: Sc, Saccharomyces cerevisiae; Sp, Schizosaccharomyces pombe; Hs, Homo sapiens; Pj, Pneumocystis jirovecii; Pc, Pneumocystis carinii; Pm, Pneumocystis murina; Pl, Protomyces lactucaedebilis. HP, hypothetical protein for which the organism (in parentheses) and identity are for the closest species not P. murina in origin.
FIG 4Validation of RNA-seq mRNA expression data by real-time quantitative PCR. Total RNA was extracted from P. murina-infected mice treated with anidulafungin for 2 weeks and nontreated infected mice. cDNA was synthesized from total RNA and used as the template for RT-qPCR. The relative quantity of Gas4/5p was upregulated, while Mam2 has decreased expression, validating RNA-seq data. Tscd is shown as a control representing a gene with no gene expression regulation. The red dotted line indicates baseline expression in untreated mice. Error bars indicate standard error of the mean (SEM). n.s., not significant.
Primers used for RT-PCR
| Gene target | Primer | Primer sequence 5′→3′ | Accession no. |
|---|---|---|---|
| Forward | TCATGGTGTTCTCCTTCCTCAT | ||
| Reverse | GGCCTTGGGACTGCTCTATT | ||
| Forward | TGGCACTTGTCCTTATGTTGAC | ||
| Reverse | AGGTGCCTGACAAATAAGCA | ||
| Forward | CCACACGAAGCATCATGGATTC | ||
| Reverse | GCTGGATGTAGAGCCACATC |